Therapy Areas: Vaccines
Labcorp, the US Department of Health and Human Services Team to Raise Awareness of COVID-19 Treatments
12 May 2021 - - US-based life sciences company Labcorp (NYSE: LH) is working with the US Department of Health and Human Services to raise awareness of potentially lifesaving monoclonal antibody COVID-19 therapies, the company said.

Patients who test positive using Labcorp's COVID-19 PCR test will receive information about monoclonal antibody therapeutics with their result.

Additionally, Labcorp's COVID-19 site provides information about treatments and vaccines, including monoclonal antibody therapies, and answers a variety of questions related to testing options.

As of May 7, Labcorp has processed more than 41 m COVID-19 PCR tests.

Monoclonal antibody treatments are laboratory-made proteins that mimic the immune system's ability to fight off harmful pathogens such as the virus that causes COVID-19.

Two such treatments currently have emergency use authorization from the US Food and Drug Administration.

People who are at high risk for progressing to severe COVID-19 or hospitalization can potentially reduce their risk of becoming very ill by receiving a monoclonal antibody treatment within the first 10 days of illness.

Early evidence suggests that monoclonal antibody treatments can reduce the amount of SARS-CoV-2, the virus that causes COVID-19, in a person's system, which decreases the likelihood of severe symptoms and hospitalization.

Labcorp's COVID-19 PCR test has not been FDA-cleared or approved; it has been authorized by the FDA under an EUA only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens.

The test is authorized only for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b) (1) of the Act, 21 USC. § 360bbb-3(b) (1), unless the authorization is terminated or revoked sooner.

Labcorp has diagnostics and drug development capabilities, more than 70,000 employees, and serves clients in more than 100 countries.

HHS works to enhance and protect the health and well-being of all Americans, providing for effective health and human services and fostering advances in medicine, public health, and social services.